Conversely, in malignancies such as renal cell carcinoma and breast cancer, IL-18 manifests prototypical antitumour characteristics, including enhanced immune surveillance and tumour cell apoptosis induction56. Here, IL18 is linked to hereditary clear cell renal cell carcinoma.